大葉大學圖書館 |

Hodgkin lymphoma[electronic resource] :a comprehensive overview /

レコード種別:	言語・文字資料 (印刷物) : 単行資料
[NT 15000414] null:	616.99446
タイトル / 著者:	Hodgkin lymphoma : a comprehensive overview // edited by Andreas Engert, Anas Younes.
その他の著者:	Engert, Andreas.
出版された:	Cham : : Springer International Publishing :, 2015.
記述:	xv, 437 p. : : ill. (some col.), digital ;; 24 cm.
含まれています:	Springer eBooks
主題:	Hodgkin's disease.
主題:	Medicine & Public Health.
主題:	Hematology.
主題:	Oncology.
国際標準図書番号 (ISBN) :	9783319125053 (electronic bk.)
国際標準図書番号 (ISBN) :	9783319125046 (paper)
[NT 15000228] null:	Part I: From Hodgkin's disease to Hodgkin Lymphoma: Epidemiology -- The role of viruses in the genesis of Hodgkin Lymphoma -- Pathology and molecular pathology of Hodgkin Lymphoma -- Microenvironment, cross-talk and immune escape mechanisms -- What will we learn from Genomics and Proteomics in Hodgkin Lymphoma? Part II: Diagnosis and treatment:Clinical evaluation -- Functional imaging -- Prognostic factors -- Principles of radiation techniques in Hodgkin Lymphoma -- Principles of chemotherapy in Hodgkin Lymphoma -- Treatment of early favorable Hodgkin Lymphoma -- Treatment of early unfavorable Hodgkin Lymphoma -- Treatment of advanced-stage Hodgkin Lymphoma -- Relapsed and refractory Hodgkin Lymphoma -- Paediatric Hodgkin Lymphoma. Part III: Special Clinical Situations: Lymphocyte-predominant Hodgkin Lymphoma -- The management of Hodgkin Lymphoma during pregnancy -- The management of HIV-Hodgkin Lymphoma -- The management of elderly patients with Hodgkin Lymphoma -- Allogeneic transplantation for relapsed of Hodgkin Lymphoma -- Targeting CD 30 -- Other new agents for patients with Hodgkin Lymphoma. Part IV: Survivorship: Quality of Life in Hodgkin Lymphoma -- Second malignancy risk after treatment of Hodgkin Lymphoma -- Cardiovascular and pulmonary late effects -- Gonadal dysfunction and fertility preservation in Hodgkin Lymphoma patients.
[NT 15000229] null:	This book examines in detail the current treatment options for first-line, relapsed, and refractory Hodgkin lymphoma and the management appropriate in special clinical circumstances, including in the elderly, pregnant women, and those with lymphocyte-predominant disease. Careful attention is devoted to the emerging individually tailored treatment strategies that are especially appealing given their potential to reduce early and late treatment side effects in this generally young patient population. In addition, clear guidance is provided on the management of Hodgkin survivors. Other topics addressed include epidemiology, pathogenesis, the role of the microenvironment, initial clinical evaluation, imaging diagnosis, use of staging systems, and prognostic factors. The second edition of Hodgkin Lymphoma: A Comprehensive Overview has been revised and updated by the key opinion leaders to reflect recent progress in the field. It will be of great value to hematologists, oncologists, and all others with an interest in Hodgkin lymphoma. .
電子資源:	http://dx.doi.org/10.1007/978-3-319-12505-3

Hodgkin lymphoma[electronic resource] :a comprehensive overview /
Hodgkin lymphomaa comprehensive overview /[electronic resource] :edited by Andreas Engert, Anas Younes. - 2nd ed. - Cham :Springer International Publishing :2015. - xv, 437 p. :ill. (some col.), digital ;24 cm. - Hematologic malignancies,2197-9766. - Hematologic malignancies..

Part I: From Hodgkin's disease to Hodgkin Lymphoma: Epidemiology -- The role of viruses in the genesis of Hodgkin Lymphoma -- Pathology and molecular pathology of Hodgkin Lymphoma -- Microenvironment, cross-talk and immune escape mechanisms -- What will we learn from Genomics and Proteomics in Hodgkin Lymphoma? Part II: Diagnosis and treatment:Clinical evaluation -- Functional imaging -- Prognostic factors -- Principles of radiation techniques in Hodgkin Lymphoma -- Principles of chemotherapy in Hodgkin Lymphoma -- Treatment of early favorable Hodgkin Lymphoma -- Treatment of early unfavorable Hodgkin Lymphoma -- Treatment of advanced-stage Hodgkin Lymphoma -- Relapsed and refractory Hodgkin Lymphoma -- Paediatric Hodgkin Lymphoma. Part III: Special Clinical Situations: Lymphocyte-predominant Hodgkin Lymphoma -- The management of Hodgkin Lymphoma during pregnancy -- The management of HIV-Hodgkin Lymphoma -- The management of elderly patients with Hodgkin Lymphoma -- Allogeneic transplantation for relapsed of Hodgkin Lymphoma -- Targeting CD 30 -- Other new agents for patients with Hodgkin Lymphoma. Part IV: Survivorship: Quality of Life in Hodgkin Lymphoma -- Second malignancy risk after treatment of Hodgkin Lymphoma -- Cardiovascular and pulmonary late effects -- Gonadal dysfunction and fertility preservation in Hodgkin Lymphoma patients.

This book examines in detail the current treatment options for first-line, relapsed, and refractory Hodgkin lymphoma and the management appropriate in special clinical circumstances, including in the elderly, pregnant women, and those with lymphocyte-predominant disease. Careful attention is devoted to the emerging individually tailored treatment strategies that are especially appealing given their potential to reduce early and late treatment side effects in this generally young patient population. In addition, clear guidance is provided on the management of Hodgkin survivors. Other topics addressed include epidemiology, pathogenesis, the role of the microenvironment, initial clinical evaluation, imaging diagnosis, use of staging systems, and prognostic factors. The second edition of Hodgkin Lymphoma: A Comprehensive Overview has been revised and updated by the key opinion leaders to reflect recent progress in the field. It will be of great value to hematologists, oncologists, and all others with an interest in Hodgkin lymphoma. .

ISBN: 9783319125053 (electronic bk.)

Standard No.: 10.1007/978-3-319-12505-3doiSubjects--Topical Terms:

406009
Hodgkin's disease.

LC Class. No.: RC644

Dewey Class. No.: 616.99446

Hodgkin lymphoma[electronic resource] :a comprehensive overview /
LDR:03423nam a2200337 a 4500 001 426466
003 DE-He213
005 20150904154229.0
006 m d
007 cr nn 008maaau
008 151119s2015 gw s 0 eng d
020 $a 9783319125053 (electronic bk.)
020 $a 9783319125046 (paper)
024 7 $a 10.1007/978-3-319-12505-3 $2 doi
035 $a 978-3-319-12505-3
040 $a GP $c GP
041 0 $a eng
050 4 $a RC644
072 7 $a MJF $2 bicssc
072 7 $a MED038000 $2 bisacsh
082 0 4 $a 616.99446 $2 23
090 $a RC644 $b .H689 2015
245 0 0 $a Hodgkin lymphoma $h [electronic resource] : $b a comprehensive overview / $c edited by Andreas Engert, Anas Younes.
250 $a 2nd ed.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2015.
300 $a xv, 437 p. : $b ill. (some col.), digital ; $c 24 cm.
490 1 $a Hematologic malignancies, $x 2197-9766
505 0 $a Part I: From Hodgkin's disease to Hodgkin Lymphoma: Epidemiology -- The role of viruses in the genesis of Hodgkin Lymphoma -- Pathology and molecular pathology of Hodgkin Lymphoma -- Microenvironment, cross-talk and immune escape mechanisms -- What will we learn from Genomics and Proteomics in Hodgkin Lymphoma? Part II: Diagnosis and treatment:Clinical evaluation -- Functional imaging -- Prognostic factors -- Principles of radiation techniques in Hodgkin Lymphoma -- Principles of chemotherapy in Hodgkin Lymphoma -- Treatment of early favorable Hodgkin Lymphoma -- Treatment of early unfavorable Hodgkin Lymphoma -- Treatment of advanced-stage Hodgkin Lymphoma -- Relapsed and refractory Hodgkin Lymphoma -- Paediatric Hodgkin Lymphoma. Part III: Special Clinical Situations: Lymphocyte-predominant Hodgkin Lymphoma -- The management of Hodgkin Lymphoma during pregnancy -- The management of HIV-Hodgkin Lymphoma -- The management of elderly patients with Hodgkin Lymphoma -- Allogeneic transplantation for relapsed of Hodgkin Lymphoma -- Targeting CD 30 -- Other new agents for patients with Hodgkin Lymphoma. Part IV: Survivorship: Quality of Life in Hodgkin Lymphoma -- Second malignancy risk after treatment of Hodgkin Lymphoma -- Cardiovascular and pulmonary late effects -- Gonadal dysfunction and fertility preservation in Hodgkin Lymphoma patients.
520 $a This book examines in detail the current treatment options for first-line, relapsed, and refractory Hodgkin lymphoma and the management appropriate in special clinical circumstances, including in the elderly, pregnant women, and those with lymphocyte-predominant disease. Careful attention is devoted to the emerging individually tailored treatment strategies that are especially appealing given their potential to reduce early and late treatment side effects in this generally young patient population. In addition, clear guidance is provided on the management of Hodgkin survivors. Other topics addressed include epidemiology, pathogenesis, the role of the microenvironment, initial clinical evaluation, imaging diagnosis, use of staging systems, and prognostic factors. The second edition of Hodgkin Lymphoma: A Comprehensive Overview has been revised and updated by the key opinion leaders to reflect recent progress in the field. It will be of great value to hematologists, oncologists, and all others with an interest in Hodgkin lymphoma. .
650 0 $a Hodgkin's disease. $3 406009
650 1 4 $a Medicine & Public Health. $3 463493
650 2 4 $a Hematology. $3 381913
650 2 4 $a Oncology. $3 205017
700 1 $a Engert, Andreas. $3 606523
700 1 $a Younes, Anas. $3 606524
710 2 $a SpringerLink (Online service) $3 463450
773 0 $t Springer eBooks
830 0 $a Hematologic malignancies. $3 467696
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-12505-3
950 $a Medicine (Springer-11650)